The Breast
Издатель: Elsevier · ISSN 0960-9776 · 38 статей
- Prospective assessment of incomplete ovarian suppression in breast cancer using LC-MS/MS and immunoassays for estradiol
- Belgian validation of the INFLUENCE 3.0 model predicting 5-year locoregional and contralateral breast cancer recurrence
- Clinical features associated with exceptional response on first-line anti-HER2-based therapy for metastatic breast cancer: real-world data from the ESME national cohort
- Chemotherapy outcomes in human epidermal growth factor receptor 2-low, hormone receptor-positive metastatic breast cancer: Insights from the French multicenter ESME database
- To stop or not to stop? International physician survey on HER2 targeted therapy for metastatic breast cancer patients in remission
- Can CanAssist Breast guide the duration of extended endocrine therapy?
- Time to maximal response of trastuzumab deruxtecan in patients with HER2-Positive metastatic breast cancer: A multicenter retrospective study (TRACE)
- Can surgical axillary staging be safely omitted in early-stage invasive lobular carcinoma? Results from a large multicenter retrospective study